Investors in Germany

They invest in Hessian companies at the start-up and early stages, in technology-oriented start-ups and university spin-offs, in innovation and growth, and in company successions. In this way, they create offers of equity and equity-like funds as an alternative to traditional loan financing.

TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanningdiscovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics.

NBank Capital invests in young, innovative companies in the seed and startup phase, N investments in SMEs with capital requirements for growth. With their investment capital in the form of silent or open investments, they support Lower Saxony startups as well as small and medium-sized companies without a specific industry or topic focus. Whether it is in the founding phase, growth, or company succession, they provide the necessary support.

Digital Health Ventures (DHV) is a sector-focused Venture Capital Fund based in Berlin. They are experienced early-stage investors with a track record that includes several strong European healthcare innovators. Their mission is to build a sustainable Digital Health ecosystem. They actively support portfolio entrepreneurs and leverage their networks in tech and healthcare. They work together closely and find joint solutions. They invest in startups which will play a significant role in healthcare and that want a strong partner during this journey.

OHA Osnabrück Healthcare Accelerator support startups from the entire healthcare sector. At OHA we support startups from the healthcare industry and life sciences. We are convinced that a future-proof healthcare system must be more digital, collaborative and diverse.

As a collective of entrepreneurs, they back green tech founders by providing capital and mentoring, offering fair terms that enable them to make choices in favor of their vision.

BlueYard invests in founders with transforming ideas that decentralize markets and empower humanity. Typically $1-3m as an initial investment; active around the world. Most active in crypto / web 3 (e.g. Protocol Labs, Filecoin, Open Zeppelin, Radicle), technologies that help us overcome our largest planetary challenges (e.g. Marvel Fusion,Meatable, Dance), frontier biology to help us live long and prosper (e.g. BitBio, Biofidelity) and vertical software un-bundling monopolies (e.g. Pitch, Wonder).

Innoport is the venture capital arm of the Schulte Group, inheriting the technology innovation, the global mindset and the Hanseatic handshake that distinguish their parent company Bernhard Schulte – a maritime innovator and operator since its own beginnings in 1883. They invest in startups globally, focusing at seed stage ventures across Europe and Asia.

RVI is a VC fund of the Vetter Pharma family office. Their mission is to support innovations that improve patients' lives. They engage early and stand alongside founders and researchers to bring outstanding ideas to the market. They invest in highly differentiated technical solutions that can become future standards of care.

Their investment focus is on digital businesses in the fields of Science, Education and Content which is grounded in deep market understanding and strong domain expertise. With offices in Munich, London and Boston they follow a global approach and back convincing business models with their experience, network and background aiming for the nextlevel of growth. Partnering with the founders and management teams of their companies is key for them. They regularly work closely together and support with strategic and operational advice. The joint goal is to ensure operational success and to create economic value. ​

Delivery Hero Ventures' mission is to support the next generation of founder-led technology companies that are disrupting some of the most fast-moving industries around the world.

Blockarm provides semi-institutional investors with exposure to game-changing protocols of the future. With their industry know-how and tools, they enable their investors to expand their portfolios and tap into this massively growing asset class with conviction.